Intrathecal alemtuzumab: a potential treatment of refractory leptomeningeal T-cell prolymphocytic leukemia

被引：6
作者：
Alsawah, Fares [1 ]
Benitez, Lydia [2 ]
Choi, Sarah [3 ]
Marini, Bernard [2 ]
Perissinotti, Anthony [2 ]
Skyles, Amy [2 ]
Burke, Patrick [4 ]
Pettit, Kristen [4 ]
Crouch, Ashley [4 ]
Fox, Heather [4 ]
Bixby, Dale [4 ]
机构：
[1] Michigan Med, Dept Internal Med, Ann Arbor, MI USA
[2] Michigan Med, Dept Pharm Serv & Clin Sci, Ann Arbor, MI USA
[3] Univ Michigan, Michigan Med, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Michigan Med, Dept Internal Med, Div Hematol & Med Oncol, F4811A UH South,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA
来源：
BLOOD ADVANCES | 2019年 / 3卷 / 21期
关键词：
ANTIBODY;
D O I：
10.1182/bloodadvances.2019000289
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3333 / 3336
页数：4
相关论文
共 13 条
  • [1] High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
    Dearden, CE
    Matutes, E
    Cazin, B
    Tjonnfjord, GE
    Parreira, A
    Nomdedeu, B
    Leoni, P
    Clark, FJ
    Radia, D
    Rassam, SMB
    Roques, T
    Ketterer, N
    Brito-Babapulle, V
    Dyer, MJS
    Catovsky, D
    [J]. BLOOD, 2001, 98 (06) : 1721 - 1726
  • [2] Management of prolymphocytic leukemia
    Dearden, Claire
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 361 - 367
  • [3] Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route
    Dearden, Claire E.
    Khot, Amit
    Else, Monica
    Hamblin, Mike
    Grand, Effie
    Roy, Ashok
    Hewamana, Saman
    Matutes, Estella
    Catovsky, Daniel
    [J]. BLOOD, 2011, 118 (22) : 5799 - 5802
  • [4] DYER MJS, 1989, BLOOD, V73, P1431
  • [5] Phase I trial of nelarabine in indolent leukemias
    Gandhi, Varsha
    Tam, Constantine
    O'Brien, Susan
    Jewell, Roxanne C.
    Rodriguez, Carlos O., Jr.
    Lerner, Susan
    Plunkett, William
    Keating, Michael J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1098 - 1105
  • [6] Central Nervous System Involvement of T-cell Prolymphocytic Leukemia Diagnosed with Stereotactic Brain Biopsy: Case Report
    Gocmen, Selcuk
    Kutlay, Murat
    Erikci, Alev
    Atabey, Cem
    Sayan, Ozkan
    Haholu, Aptullah
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2014, 31 (01) : 75 - 78
  • [7] HALE G, 1988, LANCET, V2, P1394
  • [8] HALE G, 1983, BLOOD, V62, P873
  • [9] Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed
    Keating, MJ
    Cazin, B
    Coutré, S
    Birhiray, R
    Kovacsovics, T
    Langer, W
    Leber, B
    Maughan, T
    Rai, K
    Tjonnfjord, G
    Bekradda, M
    Itzhaki, M
    Hérait, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 205 - 213
  • [10] T-cell prolymphocytic leukemia
    Khot, Amit
    Dearden, Claire
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) : 365 - 371
12